Longevity Health Holdings, Inc. (XAGE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Longevity Health Holdings, Inc. (XAGE) has a cash flow conversion efficiency ratio of 0.070x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-485.29K) by net assets ($-6.89 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see XAGE stock market capitalisation for the company's overall valuation and market capitalisation.
Longevity Health Holdings, Inc. - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how Longevity Health Holdings, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Longevity Health Holdings, Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Longevity Health Holdings, Inc. ranked by their cash flow conversion efficiency. Explore Longevity Health Holdings, Inc. earnings quality ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Devolver Digital Inc
LSE:DEVO
|
0.146x |
|
Alkemy Capital Investments Plc
LSE:ALK
|
1.013x |
|
Storage Drop Storage Technologies Ltd
TA:STRG
|
0.581x |
|
PETREL RESOURCES (PQ4.SG)
STU:PQ4
|
0.088x |
|
ROBUS GROUP AS EO -60
F:LH2
|
N/A |
|
EGR EXPL LTD
F:Z0R
|
-0.091x |
|
Fashion Bel Air S.A
PA:ALFBA
|
0.029x |
|
CENTAURUS ENERGY INC.
F:72M0
|
-0.038x |
Annual Cash Flow Conversion Efficiency for Longevity Health Holdings, Inc. (2021–2025)
The table below shows the annual cash flow conversion efficiency of Longevity Health Holdings, Inc. from 2021 to 2025. View Longevity Health Holdings, Inc. stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $-5.87 Million | $-3.33 Million | 0.567x | -39.07% |
| 2024-12-31 | $-4.71 Million | $-4.39 Million | 0.931x | +376.10% |
| 2023-12-31 | $24.75 Million | $-8.35 Million | -0.337x | -434.49% |
| 2022-12-31 | $-37.79 Million | $-3.81 Million | 0.101x | +153.45% |
| 2021-12-31 | $-29.58 Million | $-1.18 Million | 0.040x | -- |
About Longevity Health Holdings, Inc.
Longevity Health Holdings, Inc., a bio-aesthetics company, focuses on developing, manufacturing, and marketing cosmetic skincare and haircare products. The company utilizes Carmell Secretome and Elevai Exosomes to support skin and hair health. Its Carmell Secretome consists of growth factors, proteins, and peptides extracted from allogeneic human platelets; and Elevai Exosomes constains growth fa… Read more